Edition:
United States

Codexis Inc (CDXS.OQ)

CDXS.OQ on NASDAQ Stock Exchange Global Select Market

4.90USD
13 Jan 2017
Change (% chg)

-- (--)
Prev Close
$4.90
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
24,749
52-wk High
$5.20
52-wk Low
$2.93

CDXS.OQ

Chart for CDXS.OQ

About

Codexis, Inc. is a developer of biocatalysts for the pharmaceutical and fine chemicals markets. The Company's CodeEvolver protein engineering technology platform, which introduces genetic mutations into genes in order to give rise to changes in the enzymes that they produce, overcomes many of the limitations, allowing customers... (more)

Overall

Beta: -0.96
Market Cap(Mil.): $201.98
Shares Outstanding(Mil.): 41.22
Dividend: --
Yield (%): --

Financials

  CDXS.OQ Industry Sector
P/E (TTM): -- 46.47 30.92
EPS (TTM): -0.14 -- --
ROI: -18.35 -0.87 14.82
ROE: -23.19 -0.56 16.24

BRIEF-Codexis reports Q3 adj. earnings per share $0.09

* Codexis reports financial results for the third quarter of 2016

Nov 08 2016

BRIEF-Codexis reports Q2 adj. earnings per share $0.12

* Codexis reports financial results for the second quarter of 2016

Aug 09 2016

Competitors

  Price Chg
Kao Corp (4452.T) ¥5,354 -19.00
Royal Dutch Shell Plc (RDSa.AS) €25.91 -0.05
Royal Dutch Shell Plc (RDSb.L) 2,366.00p -5.00
BP plc (BP.L) 510.60p -2.00
BP plc (BP_p.L) 150.75p +0.25
BP plc (BP_pb.L) 165.00p +0.50
Sasol Limited (SOLJ.J) 42,838.00c -62.00
Sasol Limited (SOLBE1J.J) 34,000.00c --
BASF SE (BASFn.DE) €88.16 -0.13
Pfizer Inc. (PFE.N) $32.52 -0.08

Earnings vs. Estimates